evidencegaps
Primary study · included by 1 review

Efficacy and safety of botulinum A toxin for the treatment of chronic peripheral neuropathic pain: A systematic review of randomized controlled trials and meta-analysis.

Hary 2022 · Hary Vincent, Schitter Sebastien, Martinez Valeria · European journal of pain (London, England) · 2022

Included by

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.
Non-Cochrane · intervention · 2026 · cited as Hary 2022 · Table 1; Results (Study Selection); reference list (included systematic review)

The review does not say which of its outcomes this study informs.

1 including review in total.